Theriva Biologics
Price & Volume
Stats
See more52W Range | $0.17-$2.03 |
Market Cap | $7.9M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $2.06 |
News
See moreYahoo Finance • 12 days ago
Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico
Yahoo Finance • 12 days ago
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Yahoo Finance • 2 months ago
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2025
Yahoo Finance • 3 months ago
Theriva Biologics Provides Response to Unusual Market Action
About
CEO | Mr. Steven A. Shallcross CPA |
CFO | Mr. Steven A. Shallcross CPA |
Address | 9605 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
